AKT1 and prostate cancer: These results contrasted with a previous study showing that SCD repression in prostate cancer cells led to a decrease in AKT phosphorylation due to a reduction in the phosphatidylinositol‐3,4,5‐trisposphate (PIP3) content in cells 32.